The healthcare industry is entering a new era where convergent technologies are key to the success of various industry players. In the face of this increasingly complex and competitive business environment, it is extremely important to keep ahead of the crowd both in understanding and in developing the most innovative technologies, the blockbusters of the future.
The total market for drug-device combinations worldwide was valued at $5.4 billion in 2004 and is expected to rise at an average annual growth rate of 13.6% to $11.5 billion in 2010.
Source: BBC Inc.
The worldwide market for drug eluting stents will increase from $2.1 billion in 2003 up to $6.3 billion in 2008. The worldwide combination product market will increase from $6 billion in 2004 to $10 billion in 2009.
Source: Navigant Consulting
The Freedonia Group projects that nanotechnology will account for drug delivery and biomedical product demand of $3.7 billion in 2009, up from $165 million in 2004. The largest share of opportunities will emerge in pharmaceutical applications, which are expected to reach $3.1billion in 2009 and expand to $18 billion in 2014.
Source: The Freedonia Group
Position yourself for success by knowing the latest trends and the challenges you face.
Start building your network in the convergent medical technology space today by joining us in Edinburgh for BioDevice Partnering 2006!
|
